Nonprofit · EIN 52-6063009
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC
Tax-exempt · WASHINGTON, DC 20024
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $4,902,599 | $5,201,229 | -$298,630 | $28,801,189 | $1,517,326 | $27,283,863 |
| December 31, 2024 | 990 (amended) | $4,293,133 | $4,981,861 | -$688,728 | $27,568,119 | $1,540,685 | $26,027,434 |
| December 31, 2023 | 990 | $4,244,730 | $4,366,003 | -$121,273 | $24,481,309 | $404,521 | $24,076,788 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $2,829,510
- Program service revenue
- $0
- Investment income
- $2,073,089
- Net gain from sales of assets
- $1,517,449
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $3,708,833
- Compensation of officers, directors and key employees
- $613,926
- Other salaries and wages
- $326,105
- Salaries, compensation and benefits (total)
- $1,144,793
- Professional fundraising fees
- $0
- Accounting fees
- $31,130
- Travel
- $16,608
- Depreciation
- $32,727
- Program services (functional)
- $4,634,099
- Management and general (functional)
- $563,896
- Fundraising (functional)
- $3,234
Balance sheet and other
- Total assets, start of year
- $27,568,119
- Total assets, end of year
- $28,801,189
- Total liabilities, end of year
- $1,517,326
- Net assets, end of year
- $27,283,863
- Land, buildings and equipment
- $27,272
- Publicly traded securities
- $26,348,573
- Net assets without donor restrictions
- $27,283,863
- Gross receipts
- $11,443,308
- Employees
- 4
- Volunteers
- 85
- Year formed
- 1965
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AMY MILLER | PRESIDENT Officer | 37.5 | $535,515 | $78,411 |
| EMILY ORTMAN | SENIOR DIRECTOR Highest-paid employee | 37.5 | $204,960 | $64,962 |
| JOANNE WESTPHAL | DIRECTOR Highest-paid employee | 37.5 | $184,732 | $37,717 |
| ANDREW PLUMP MD PHD | CHAIRMAN Trustee or director, Officer | 1 | $0 | $0 |
| AIDA HABTEZION MD MSC FRCP | DIRECTOR (THRU 3/2025) Trustee or director | 1 | $0 | $0 |
| DANIEL SKOVRONSKY MD PhD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DONATELLO CROCETTA | Director Trustee or director | 1 | $0 | $0 |
| FIONA H MARSHALL PHD FMedSci FRS | DIRECTOR (AS OF 6/2025) Trustee or director | 1 | $0 | $0 |
| GEORGE ADDONA PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN REED MD PhD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LORI REILLY Esq | EX OFFICIO MEMBER Trustee or director | 1 | $0 | $0 |
| PATRIZIA CAVAZZONI MD | DIRECTOR (AS OF 6/2025) Trustee or director | 1 | $0 | $0 |
| ROBERT PLENGE MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2024: 14 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AMY MILLER | PRESIDENT Officer | 37.5 | $515,068 | $72,837 |
| EMILY ORTMAN | SENIOR DIRECTOR Highest-paid employee | 37.5 | $198,869 | $58,730 |
| JOANNE WESTPHAL | DIRECTOR Highest-paid employee | 37.5 | $178,835 | $36,213 |
| ANDREW PLUMP MD PHD | CHAIRMAN Trustee or director, Officer | 1 | $0 | $0 |
| DONATELLO CROCETTA | TREASURER (AS OF 12/24) Trustee or director, Officer | 1 | $0 | $0 |
| IRIS LOEW-FRIEDRICH MD | TREASURER (THRU 12/24) Trustee or director, Officer | 1 | $0 | $0 |
| AIDA HABTEZION MD MSC FRCP | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ARAN MAREE MB BCH MRCIP | DIRECTOR (THRU 10/24) Trustee or director | 1 | $0 | $0 |
| DANIEL SKOVRONSKY MD PhD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GEORGE ADDONA PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN REED MD PhD | DIRECTOR (AS OF 12/24) Trustee or director | 1 | $0 | $0 |
| LORI REILLY Esq | EX OFFICIO MEMBER Trustee or director | 1 | $0 | $0 |
| MAHA RADHAKRISHNAN MD | DIRECTOR (THRU 03/24) Trustee or director | 1 | $0 | $0 |
| ROBERT PLENGE MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 14 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AMY MILLER | PRESIDENT Officer | 37.5 | $473,105 | $71,183 |
| Emily Ortman | Senior Director Highest-paid employee | 37.5 | $181,481 | $56,873 |
| Joanne Westphal | Director Highest-paid employee | 37.5 | $171,183 | $34,576 |
| Andrew Plump MD PhD | Chairman Trustee or director, Officer | 1 | $0 | $0 |
| Iris Loew-Friedrich MD | Treasurer Trustee or director, Officer | 1 | $0 | $0 |
| George Addona PhD | Director Trustee or director | 1 | $0 | $0 |
| Aida Habtezion MD MSc FRCP | Director Trustee or director | 1 | $0 | $0 |
| Aran Maree MB BCH MRCIP | Director Trustee or director | 1 | $0 | $0 |
| Robert Plenge MD PhD | Director Trustee or director | 1 | $0 | $0 |
| Maha Radhakrishnan MD | Director Trustee or director | 1 | $0 | $0 |
| Daniel Skovronsky MD PhD | Director Trustee or director | 1 | $0 | $0 |
| John Creed MD PHD | Director (thru 2/28/2023) Trustee or director | 1 | $0 | $0 |
| Rupert Vessey MA BM BCh | Director (thru 6/4/2023) Trustee or director | 1 | $0 | $0 |
| Lori Reilly Esq | Ex Officio member Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 670 MAINE AVE SW, WASHINGTON, DC 20024-3556
- In care of
- % TRACEY MERCHANT
- Principal officer (990 for 2025)
- AMY MILLER, 670 MAINE AVENUE SW 1000, WASHINGTON, DC 20024
- Signed the 990
- AMY MILLER, PRESIDENT
- Phone
- (202) 572-7756
- Website
- WWW.PHRMAFOUNDATION.ORG
- Return prepared by
- BDO USA
Mission
THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE.
Program accomplishments
- Drug Discovery - funds early career academic scientists who are pioneering new approaches to drug discovery. We support research projects that have the potential to make a significant impact for patients. By funding the drug discovery research of promising young scientists, the Foundation helps accelerate the identification of new therapeutic compounds and modalities while building a talent base to support innovation across the biopharmaceutical industry.Expenses $1,341,859 · grants $1,085,952
- Drug Delivery - Funds researchers studying ways to optimize drug composition, dosage, and delivery to make treatments safer, more effective, and easier to manage for patients.Expenses $1,055,367 · grants $856,250
- Value Assessment-Health Outcomes Research (VA-HOR) - supports early career researchers engaged in a multidisciplinary, collaborative research that investigates challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions.Expenses $901,315 · grants $739,986
- Translational Medicine - Funds novel research that uses the "bedside to bench" approach to address unmet needs in the diagnosis, treatment, and prevention of disease. The Foundation supports early career researchers focused on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.Expenses $864,045 · grants $693,309
- DIGITAL HEALTH TECHNOLOGIES - SUPPORTS RESEARCH ON THE USE OF DHTS IN UNDERREPRESENTED POPULATIONS IN CLINICAL TRIALS TO ADVANCE FDA REGULATORY DECISION MAKING.Expenses $410,148 · grants $333,336
- Other Program ExpensesExpenses $61,365
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 52-6063009
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1965
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $28,801,189
- Income (IRS master file)
- $11,443,308
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $4,902,599 | $5,201,229 | $28,801,189 | XML |
| 990 | December 2024 | $4,293,133 | $4,981,861 | $27,568,119 | XML |
| 990 | December 2023 | $4,244,730 | $4,366,003 | $24,481,309 | XML |
| 990 | December 2022 | $3,902,642 | $4,077,991 | $22,787,225 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-6063009).
Questions about PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC
- What is the EIN of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC?
- The employer identification number (EIN) of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC is 52-6063009.
- Is PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1965.
- Are donations to PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC?
- The 990 for the year ended December 31, 2025 names AMY MILLER.
- Who are the officers and directors of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC?
- The 990 for the year ended December 31, 2025 lists 13 people; 3 received compensation from the organization, the highest $535,515 (AMY MILLER, PRESIDENT).
- How much revenue does PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $4,902,599, expenses of $5,201,229 and total assets of $28,801,189 at year end.
Other nonprofits in WASHINGTON
- AARP EIN 95-1985500 · last filed 990 for 2024
- RISANT HEALTH INC EIN 92-3467590 · last filed 990 for 2024
- AMERICAN NATIONAL RED CROSS EIN 53-0196605 · last filed 990 for 2025
- GAVI ALLIANCE EIN 98-0593375 · last filed 990 for 2024
- GEORGETOWN UNIVERSITY EIN 53-0196603 · last filed 990 for 2025
- NATIONAL ASSOCIATION OF LETTER CARRIERS EIN 53-0114650 · last filed 990 for 2025
- SMITHSONIAN INSTITUTE EIN 53-0206027 · last filed 990 for 2025
- CHILDRENS HOSPITAL EIN 53-0196580 · last filed 990 for 2025